Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan

Published:2020-06-04 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Wu Chiao-En,Yang Chan-Keng,Peng Meng-Ting,Huang Pei-Wei,Lin Yu-Fen,Cheng Chi-Yuan,Chang Yao-Yu,Chen Huan-Wu,Hsieh Jia-Juan,Chang John Wen-Cheng

Funder

Chang Gung Medical Foundation

Ministry of Science and Technology

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference32 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med.,2010

2. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial;Hodi;Lancet Oncol.,2018

3. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001;Hamid;Ann Oncol.,2019

4. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;Wolchok;N Engl J Med.,2017

5. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma;Larkin;N Engl J Med.,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Adverse Reactions and Survival Outcomes of Advanced Melanoma Treated with Immune Checkpoint Inhibitors in an Academic Medical Centre in Singapore;Diagnostics;2024-07-25

2. The immune response-related genomic alterations in patients with malignant melanoma;Medicine;2024-04-26

3. Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals;The Journal of Dermatology;2024-03-12

4. Clinical practice consensus for the diagnosis and management of melanoma in Taiwan;Journal of the Formosan Medical Association;2024-01

5. Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis;Clinical & Experimental Metastasis;2023-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3